We are live on
!
Find out more
ACP
Acuta Capital Partners Portfolio holdings
AUM
$141M
1-Year Est. Return
783.79%
This Fund
S&P 500
This Quarter
Est. Return
+42.28%
1 Year Est. Return
+783.79%
3 Year Est. Return
+7,472.18%
5 Year Est. Return
+13,792.16%
10 Year Est. Return
+1,629,663.73%
AUM
$141M
AUM Growth
-$6.69M
(-4.5%)
Cap. Flow
-$27M
Cap. Flow
% of AUM
-19.21%
Top 10 Holdings %
Top 10 Hldgs %
78%
Holding
35
New
5
Increased
6
Reduced
13
Closed
9
Top Buys
| 1 |
Erasca
ERAS
|
+$4.19M |
| 2 |
Sutro Biopharma
STRO
|
+$3.65M |
| 3 |
DRUG
Bright Minds Biosciences
DRUG
|
+$2.22M |
| 4 |
Tango Therapeutics
TNGX
|
+$2.21M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
+$2.19M |
Top Sells
| 1 |
CDTX
Cidara Therapeutics
CDTX
|
+$19.7M |
| 2 |
TERN
Terns Pharmaceuticals
TERN
|
+$5.8M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$4.93M |
| 4 |
Insmed
INSM
|
+$4.5M |
| 5 |
Ocular Therapeutix
OCUL
|
+$4.39M |
Sector Composition
| 1 | Healthcare | 98.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Praxis Precision Medicines
PRAX
$9.14B
| $27.4M | 19.46% |
84,901
+1,865
| +2% | +$577K |
|
|
TERN
2
DELISTED
Terns Pharmaceuticals
TERN
| $26.1M | 18.59% |
495,772
-141,323
| -22% | -$5.8M |
|
|
WHWK
3
Whitehawk Therapeutics
WHWK
$188M
| $11.8M | 8.37% |
3,410,402
| – | – |
|
|
4
Tango Therapeutics
TNGX
$4.83B
| $9.24M | 6.57% |
441,831
+159,099
| +56% | +$2.21M |
|
|
DRUG
5
Bright Minds Biosciences
DRUG
$726M
| $8.17M | 5.81% |
111,996
+27,519
| +33% | +$2.22M |
|
|
6
Sutro Biopharma
STRO
$431M
| $6.71M | 4.77% |
269,425
+201,974
| +299% | +$3.65M |
|
|
7
Erasca
ERAS
$6.06B
| $5.74M | 4.08% |
+354,575
| New | +$4.19M |
|
8
Surrozen
SRZN
$254M
| $5.04M | 3.58% |
172,847
-5,568
| -3% | -$133K |
|
|
9
Ocular Therapeutix
OCUL
$2.12B
| $5.02M | 3.57% |
592,108
-460,887
| -44% | -$4.39M |
|
10
Compass Therapeutics
CMPX
$394M
| $4.49M | 3.19% |
849,076
-244,224
| -22% | -$1.41M |
|
11
Minerva Neurosciences
NERV
$187M
| $4.27M | 3.04% |
709,500
| – | – |
|
|
12
MoonLake Immunotherapeutics
MLTX
$1.63B
| $3.57M | 2.54% |
191,760
+132,480
| +223% | +$2.19M |
|
13
argenx
ARGX
$53.4B
| $3.42M | 2.44% |
4,690
-161
| -3% | -$126K |
|
14
Oculis Holding
OCS
$781M
| $2.61M | 1.86% |
98,339
-3,438
| -3% | -$91K |
|
15
Revolution Medicines
RVMD
$39.3B
| $2.54M | 1.8% |
26,069
+17,658
| +210% | +$1.78M |
|
16
Amylyx Pharmaceuticals
AMLX
$2.02B
| $2.1M | 1.49% |
151,067
-182,191
| -55% | -$2.56M |
|
17
Taysha Gene Therapies
TSHA
$1.64B
| $1.96M | 1.4% |
439,464
-15,363
| -3% | -$71.4K |
|
18
IDEAYA Biosciences
IDYA
$3.53B
| $1.61M | 1.14% |
+48,234
| New | +$1.62M |
|
19
Design Therapeutics
DSGN
$854M
| $1.55M | 1.1% |
145,900
-5,006
| -3% | -$50.7K |
|
20
United Therapeutics
UTHR
$22.4B
| $1.32M | 0.94% |
2,224
-72
| -3% | -$35.9K |
|
21
Entrada Therapeutics
TRDA
$264M
| $1.13M | 0.8% |
+89,358
| New | +$1.02M |
|
22
Avalo Therapeutics
AVTX
$968M
| $908K | 0.65% |
+60,808
| New | +$951K |
|
|
LBRX
23
LB Pharmaceuticals
LBRX
$918M
| $713K | 0.51% |
28,919
-1,081
| -4% | -$24.9K |
|
|
MAZE
24
Maze Therapeutics
MAZE
$1.65B
| $577K | 0.41% |
19,335
-665
| -3% | -$29.3K |
|
25
Unicycive Therapeutics
UNCY
$143M
| $381K | 0.27% |
57,959
-2,026
| -3% | -$13.3K |
|
Similar funds
MQWP
OWM
VT
API
APW
SM
VEM
MWM